Login / Signup

Ferroptosis: Final destination for cancer?

Zeng YeWensheng LiuQifeng ZhuoQiangsheng HuMengqi LiuQiqing SunZheng ZhangGuixiong FanWenyan XuShunrong JiXian-Jun YuYi QinXiao-Wu Xu
Published in: Cell proliferation (2020)
Ferroptosis is a recently defined, non-apoptotic, regulated cell death (RCD) process that comprises abnormal metabolism of cellular lipid oxides catalysed by iron ions or iron-containing enzymes. In this process, a variety of inducers destroy the cell redox balance and produce a large number of lipid peroxidation products, eventually triggering cell death. However, in terms of morphology, biochemistry and genetics, ferroptosis is quite different from apoptosis, necrosis, autophagy-dependent cell death and other RCD processes. A growing number of studies suggest that the relationship between ferroptosis and cancer is extremely complicated and that ferroptosis promises to be a novel approach for the cancer treatment. This article primarily focuses on the mechanism of ferroptosis and discusses the potential application of ferroptosis in cancer therapy.
Keyphrases
  • cell death
  • cell cycle arrest
  • cancer therapy
  • papillary thyroid
  • stem cells
  • squamous cell
  • squamous cell carcinoma
  • drug delivery
  • single cell
  • transcription factor
  • young adults
  • risk assessment